Magazine Article | September 1, 2015

Making Britain The "Fastest Place" For Pharma R&D Adoption

Source: Life Science Leader

By Neal Learner, Contributing Editor

Competition in the pharmaceutical industry isn’t just about which manufacturer discovers the next blockbuster pill. National governments and entire geographical regions compete fiercely to attract pharma companies and the billions of dollars that come with their high-value investments. The United Kingdom is the latest country to try and step up its game.

The U.K. government in June unveiled details of its Accelerated Access Review (AAR) initiative, which aims to make the U.K. nothing less than, “the fastest place in the world for the design, development, and widespread adoption of medical innovations.” British manufacturers naturally welcome the effort, but contend the country has a ways to go in meeting its ambitious goals, especially in the adoption of new medicines.